WINNIPEG, MANITOBA--(Marketwire - December 10, 2007) - Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular focused biopharmaceutical company, today announced its President and CEO, Albert D. Friesen, PhD, will participate on the “Replacing The Mainstay With Newer And Better Agents” panel at the 2007 RBC Capital Markets Healthcare Conference in New York. The panel discussion is scheduled for Wednesday, December 12th at 4:30 p.m. Eastern.
